bucindolol has been researched along with carvedilol in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 10 (27.78) | 18.2507 |
| 2000's | 19 (52.78) | 29.6817 |
| 2010's | 4 (11.11) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, MR; Handwerger, D; Klein, J; Larrabee, P; Minobe, W; Müller-Beckmann, B; Port, JD; Roden, R; Skerl, L | 2 |
| Lefflerová, K; Widimský, J | 1 |
| Asano, K; Bouvier, M; Bristow, MR; Chidiak, P; Dutcher, D; Minobe, W; Port, JD; Roden, RL; Tremmel, KD; Yoshikawa, T | 1 |
| Abraham, WT; Bristow, MR; Crisman, TS; Gilbert, EM; Hattler, BG; Larrabee, P; Lowes, BD; Robertson, AD; White, M; Yoshikawa, T | 1 |
| Lukas, MA; Mitchell, MP; Ohlstein, EH; Ruffolo, RR; Willette, RN | 1 |
| Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Roden, RL | 1 |
| Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL | 1 |
| Carson, PE | 1 |
| Eichhorn, EJ; Fesmire, SI; Kennedy, HL; Lyyski, DS; Marcoux, LG; Sprague, MK | 1 |
| Witkowska, M | 1 |
| Bristow, MR | 1 |
| Böhm, M; Cremers, B; Flesch, M; Höper, A; Maack, C; Südkamp, M | 1 |
| Hjalmarson, A | 1 |
| Krum, H; Whorlow, SL | 1 |
| Chavey, WE | 1 |
| Braunwald, E | 1 |
| Asano, K; Bristow, MR; Headley, V; Port, JD; Yoshikawa, T; Zisman, LS | 1 |
| SoRelle, R | 1 |
| Coutinho, J | 1 |
| Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH | 1 |
| Negut, C | 1 |
| Bosimini, E | 1 |
| Czuriga, I; Edes, I | 1 |
| Brodde, OE; Heinroth-Hoffmann, I; Pönicke, K | 1 |
| Cherubini, A; Di Lenarda, A; Perkan, A; Salvatore, L; Sinagra, G | 1 |
| Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A | 1 |
| Anh, D; Marine, JE | 1 |
| Coats, AJ | 1 |
| Adams, KF | 1 |
| Remme, WJ | 1 |
| Francis, GS; Sarraf, M | 1 |
| Edwards, PC; Leslie, AG; Tate, CG; Warne, T | 1 |
| Abraham, WT; Adams, KF; Blain-Nelson, P; Bristow, MR; Davis, G; Felker, GM; Fiuzat, M; Liggett, SB; Neely, M; O'Connor, CM; Parikh, KS; Whellan, DJ | 1 |
| Abraham, I; Alkhatib, N; Erstad, B; Gharaibeh, M; Karnes, J; Klimecki, W; Lee, CS; Ramos, K; Slack, M; Sweitzer, NK | 1 |
| Chang, S; Lu, S; Shen, L; Tong, X; Wang, Y; Zhou, X | 1 |
15 review(s) available for bucindolol and carvedilol
| Article | Year |
|---|---|
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
Cardiac adrenergic receptor effects of carvedilol.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Cells, Cultured; Guanine Nucleotides; Heart; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 1996 |
The role of third-generation beta-blocking agents in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Heart Failure; Humans; Propanolamines; Vasodilator Agents | 1998 |
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol | 1999 |
beta-adrenergic receptor blockade in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Heart Function Tests; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta; Signal Transduction | 2000 |
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Heart Failure; Humans; Metoprolol; Nebivolol; Propanolamines | 2000 |
The importance of beta blockers in the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Severity of Illness Index | 2000 |
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2001 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
[Treatment of heart failure: an update].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Benzazepines; Bosentan; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Heart Failure; Heart-Assist Devices; Humans; Metoprolol; Multicenter Studies as Topic; Placebos; Propanolamines; Prospective Studies; Pyridines; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2002 |
Beta blockers as anti-arrhythmic agents.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; United States | 2004 |
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Benzopyrans; Carbazoles; Carvedilol; Chronic Disease; Ethanolamines; Heart Failure; Humans; Nebivolol; Practice Guidelines as Topic; Propanolamines; Randomized Controlled Trials as Topic | 2006 |
Beta-blockers in heart failure: how far have we progressed?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2012 |
Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis.
Topics: Cardiomyopathy, Dilated; Carvedilol; Humans; Ivabradine; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke Volume; Trimetazidine; Ventricular Function, Left; Verapamil | 2023 |
2 trial(s) available for bucindolol and carvedilol
| Article | Year |
|---|---|
Second- and third-generation beta-blocking drugs in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Exercise Test; Heart Ventricles; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Propanolamines; Ventricular Function, Left | 1997 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Propanolamines; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; Statistics as Topic; Treatment Failure; Ventricular Dysfunction, Left; Withholding Treatment | 2004 |
19 other study(ies) available for bucindolol and carvedilol
| Article | Year |
|---|---|
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Culture Techniques; Cyclic AMP; Heart Failure; Heart Ventricles; Humans; Iodocyanopindolol; Lymphocytes; Myocardium; Pindolol; Propanolamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasodilator Agents | 1992 |
Receptor pharmacology of carvedilol in the human heart.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cyclic AMP; Guanylyl Imidodiphosphate; Humans; Iodocyanopindolol; Metoprolol; Myocardium; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 1992 |
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Decerebrate State; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Heart Failure; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Sympathomimetics | 1998 |
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol | 1999 |
Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Conduction System; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Retrospective Studies; Stroke Volume; Treatment Outcome | 1999 |
[The role of beta-adrenergic blocking agents in treatment of heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 1999 |
Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Carvedilol; Catecholamines; Female; Guanylyl Imidodiphosphate; Heart Failure; Humans; In Vitro Techniques; Iodocyanopindolol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Propanolamines | 2000 |
[Beta blockers: the end of controversy].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiac Output, Low; Carvedilol; Cause of Death; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Survival Rate | 2000 |
Expanding indications for beta-blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Black People; Carbazoles; Carvedilol; Heart Failure; Humans; Propanolamines; Severity of Illness Index; Survival Analysis | 2001 |
Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Cell Line; Cell Membrane; Cells, Cultured; Chick Embryo; Cricetinae; Muscle, Smooth; Myocardium; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2001 |
Beta-blocker trials seem to be in conflict.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Contraindications; Heart Failure; Humans; Propanolamines; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2001 |
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics | 2001 |
Effects of beta-blocker therapy in severe chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Propanolamines; Spironolactone; Survival Rate | 2001 |
[Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Propanolamines; Severity of Illness Index; Survival Rate | 2001 |
Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Hypertrophy, Left Ventricular; Kinetics; Male; Muscle Proteins; Myocardium; Norepinephrine; Phenylalanine; Propanolamines; Radioligand Assay; Rats; Rats, Wistar | 2002 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Crystallography, X-Ray; Humans; Models, Molecular; Propanolamines; Receptors, Adrenergic, beta-1; Turkeys | 2012 |
Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amino Acid Substitution; Carvedilol; Cause of Death; Clinical Trials as Topic; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; Mortality; Pharmacogenetics; Pharmacogenomic Testing; Polymorphism, Genetic; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Retrospective Studies | 2018 |
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure.
Topics: Antihypertensive Agents; Carvedilol; Cost-Benefit Analysis; Decision Trees; Health Expenditures; Health Services; Heart Failure; Hospitalization; Humans; Models, Econometric; Patient Acceptance of Health Care; Polymorphism, Single Nucleotide; Propanolamines; Quality-Adjusted Life Years; Racial Groups; Receptors, Adrenergic, beta-1; Stroke Volume; Trauma Severity Indices | 2021 |